Ligence receives Certificate for the Ligence Heart AI system

Ligence Heart analysis and reporting system for transthoracic echocardiography has been certified under MDR 2017/745.

The device is regulated as medical device class IIa under the framework of the European Commission.

The Ligence Heart AI system will be now offered to care centres in Europe to aid with the burdens of the echocardiography procedure.

The company expects first sales to happen in Lithuania and the Baltic region, followed by the Netherlands.

Share the Post:

Related Posts

Utilizing high-frequency sound waves, this non-invasive imaging technique offers real-time visualization of cardiac chambers, valves, and blood flow dynamics. However, alongside its imaging capabilities, the echocardiography report plays a
As a cardiology resident, the pivotal choice between specializing in imaging or interventional cardiology shapes your career trajectory in profound ways. While both paths offer distinct advantages and challenges, exploring